Aarti Drugs Live BSE/NSE | Aarti Drugs Fundamenta data | Aarti Drugs Balance sheet | Aarti Drugs Quarterly Results | Aarti Drugs Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

7,170.81
35.08
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

7,542.51
0.07%
8.88

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.68
9.64
13.24

EBITDA CAGR (%)

10 Years
5 Years
3 Years

14.40
8.11
5.63

PAT CAGR (%)

10 Years
5 Years
3 Years

19.66
15.52
19.77

P:E (Median)

8 Years
5 Years
3 Years

16.36
16.36
15.50

P:BV (Average)

8 Years
5 Years
3 Years

3.39
3.31
3.24

EV:EBITDA (Average)

8 Years
5 Years
3 Years

10.04
9.86
9.90

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 476 370 29% 407 433 -6% 416 351 19% 443 320 39%
Expenses 359 318 13% 339 380 -11% 356 300 19% 377 274 38%
EBITDA 116 52 122% 68 52 29% 59 51 16% 65 46 43%
EBIDTM 24% 14% 17% 12% 14% 15% 15% 14%
Other Income 1 0 1140% 1 1 -52% 0 0 -38% 0 0 75%
Interest 6 9 -27% 7 10 -26% 8 10 -18% 8 9 -12%
Depreciation 12 11 6% 12 10 17% 12 10 16% 12 10 15%
PBT 99 32 206% 57 38 53% 40 31 27% 46 27 72%
Tax 26 11 142% 1 12 -93% 13 10 29% 15 9 73%
PAT 73 22 239% 57 26 120% 27 21 27% 31 18 71%
PATM 15% 6% 14% 6% 6% 6% 7% 6%
EPS 31.34 9.26 238% 24.27 11.03 120% 11.48 9.08 26% 13.22 7.74 71%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 545 405 34% 450 459 -2% 474 380 25% 478 347 37%
Expenses 411 351 17% 378 403 -6% 406 328 24% 409 300 36%
EBITDA 134 55 145% 71 56 28% 67 52 30% 68 47 45%
EBIDTM 25% 13% 16% 12% 14% 14% 14% 14%
Other Income 1 0 2000% 1 1 -20% 0 0 47% 0 0 90%
Interest 7 9 -30% 7 10 -28% 8 10 -20% 9 10 -12%
Depreciation 12 12 5% 12 11 16% 12 11 15% 12 11 14%
PBT 116 34 246% 61 40 53% 43 31 40% 48 27 79%
Tax 31 11 176% 2 12 -85% 15 10 54% 16 9 79%
PAT 85 22 281% 59 27 115% 28 21 33% 32 18 79%
PATM 16% 6% 13% 6% 6% 5% 7% 5%
EPS 36.67 9.64 280% 25.26 11.78 114% 11.92 8.96 33% 13.87 7.75 79%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,740 1,635 1,454 1,140 1,089 1,076 1,087 972 826 662 496 Net Sales Growth 18% 12% 28% 5% 1% -1% 12% 18% 25% 33% Cost Of Goods Sold 1,106 1,028 951 687 673 691 718 643 536 438 329 Gross Profit 635 607 503 454 416 385 369 329 289 225 168 GP Margin 36% 37% 35% 40% 38% 36% 34% 34% 35% 34% 34% Total Expenditure 1,432 1,387 1,252 955 910 900 915 822 703 579 432 Power & Fuel Cost - 101 82 69 57 53 49 48 53 48 29 % Of Sales - 6% 6% 6% 5% 5% 5% 5% 6% 7% 6% Employee Cost - 53 47 45 43 37 33 29 25 22 16 % Of Sales - 3% 3% 4% 4% 3% 3% 3% 3% 3% 3% Manufacturing Exp. - 140 121 109 91 77 74 59 53 45 38 % Of Sales - 9% 8% 10% 8% 7% 7% 6% 6% 7% 8% General & Admin Exp. - 19 13 11 10 10 10 10 8 7 5 % Of Sales - 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% Selling & Distn. Exp. - 42 35 32 30 28 29 29 24 20 15 % Of Sales - 3% 2% 3% 3% 3% 3% 3% 3% 3% 3% Miscellaneous Exp. - 5 3 4 6 4 2 4 3 1 15 % Of Sales - 0% 0% 0% 1% 0% 0% 0% 0% 0% 0% EBITDA 308 248 203 185 179 176 172 150 123 83 65 EBITDA Margin 18% 15% 14% 16% 16% 16% 16% 15% 15% 13% 13% Other Income 2 1 6 1 4 0 1 0 0 0 0 Interest 30 36 41 36 38 47 42 37 31 25 16 Depreciation 47 47 40 38 37 36 31 28 26 24 18 PBT 242 167 128 112 108 93 100 85 66 33 31 Tax 55 39 40 39 32 27 22 24 21 10 9 Tax Rate 23% 22% 32% 35% 30% 29% 22% 28% 31% 30% 29% PAT 187 136 87 73 75 66 78 61 46 22 22 PAT before Minority Interest 187 136 87 73 75 66 78 61 46 22 22 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 11% 8% 6% 6% 7% 6% 7% 6% 6% 3% 5% PAT Growth 116% 55% 19% -3% 14% -15% 28% 33% 103% 0% EPS 80.32 58.23 37.45 31.51 32.39 28.45 33.30 26.09 19.60 9.64 9.64

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

1,740

1,635

1,454

1,140

1,089

1,076

1,087

972

826

662

496

Net Sales Growth

18%

12%

28%

-1%

12%

18%

25%

33%

Cost Of Goods Sold

1,106

1,028

951

687

673

691

718

643

536

438

329

Gross Profit

635

607

503

454

416

385

369

329

289

225

168

GP Margin

36%

37%

35%

40%

38%

36%

34%

35%

34%

Total Expenditure

1,432

1,387

1,252

955

910

900

915

822

703

579

432

Power & Fuel Cost

101

% Of Sales

Employee Cost

% Of Sales

Manufacturing Exp.

140

121

109

% Of Sales

10%

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

% Of Sales

EBITDA

308

248

203

185

179

176

172

150

123

EBITDA Margin

18%

15%

14%

16%

15%

13%

Other Income

Interest

Depreciation

PBT

242

167

128

112

108

100

Tax

Tax Rate

23%

22%

32%

35%

30%

29%

22%

28%

31%

30%

29%

PAT

187

136

PAT before Minority Interest

187

136

Minority Interest

PAT Margin

11%

PAT Growth

116%

55%

19%

-3%

14%

-15%

28%

33%

103%

EPS

80.32

58.23

37.45

31.51

32.39

28.45

33.30

26.09

19.60

9.64

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 11 Mar 10 Mar 09 Mar 08
Net Sales 1,945 1,806 1,561 1,244 1,195 1,140 1,097 501 478 382 312 Net Sales Growth 22% 16% 26% 4% 5% 4% 119% 5% 25% 22% Cost Of Goods Sold 1,229 1,127 1,014 738 744 735 724 321 301 239 197 Gross Profit 716 679 547 506 451 405 373 180 177 143 115 GP Margin 37% 38% 35% 41% 38% 36% 34% 36% 37% 37% 37% Total Expenditure 1,604 1,541 1,350 1,042 1,005 960 925 432 396 316 267 Power & Fuel Cost - 104 84 71 59 54 50 29 26 23 20 % Of Sales - 6% 5% 6% 5% 5% 5% 6% 6% 6% 6% Employee Cost - 61 55 52 48 40 33 20 15 12 11 % Of Sales - 3% 3% 4% 4% 4% 3% 4% 3% 3% 3% Manufacturing Exp. - 160 143 130 103 88 76 39 32 25 24 % Of Sales - 9% 9% 10% 9% 8% 7% 8% 7% 7% 8% General & Admin Exp. - 21 14 12 13 11 10 5 5 4 3 % Of Sales - 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% Selling & Distn. Exp. - 59 38 34 31 28 29 16 14 12 10 % Of Sales - 3% 2% 3% 3% 2% 3% 3% 3% 3% 3% Miscellaneous Exp. - 7 3 4 6 4 2 1 2 1 10 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 1% EBITDA 341 266 211 202 190 180 172 69 82 66 46 EBITDA Margin 18% 15% 14% 16% 16% 16% 16% 14% 17% 17% 15% Other Income 3 1 6 1 4 0 1 0 1 1 2 Interest 31 37 44 38 40 48 42 17 19 26 14 Depreciation 49 49 43 40 38 37 31 19 17 14 13 PBT 268 181 131 124 116 95 100 33 47 26 20 Tax 64 44 41 42 34 27 22 10 19 8 5 Tax Rate 24% 24% 32% 34% 29% 28% 23% 29% 40% 33% 26% PAT 204 141 90 82 82 69 77 24 28 17 14 PAT before Minority Interest 204 141 90 82 82 69 77 24 28 18 15 Minority Interest 0 0 0 0 0 0 0 0 0 -1 -1 PAT Margin 11% 8% 6% 7% 7% 6% 7% 5% 6% 4% 5% PAT Growth 130% 58% 9% 1% 19% -11% 229% -16% 68% 19% EPS 87.73 60.69 38.52 35.33 35.11 29.49 33.15 10.09 12.04 7.17 6.04

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 11

Mar 10

Mar 09

Mar 08

Net Sales

1,945

1,806

1,561

1,244

1,195

1,140

1,097

501

478

382

312

Net Sales Growth

22%

16%

26%

119%

25%

22%

Cost Of Goods Sold

1,229

1,127

1,014

738

744

735

724

321

301

239

197

Gross Profit

716

679

547

506

451

405

373

180

177

143

115

GP Margin

37%

38%

35%

41%

38%

36%

34%

36%

37%

Total Expenditure

1,604

1,541

1,350

1,042

1,005

960

925

432

396

316

267

Power & Fuel Cost

104

% Of Sales

Employee Cost

% Of Sales

Manufacturing Exp.

160

143

130

103

% Of Sales

10%

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

% Of Sales

EBITDA

341

266

211

202

190

180

172

EBITDA Margin

18%

15%

14%

16%

14%

17%

15%

Other Income

Interest

Depreciation

PBT

268

181

131

124

116

100

Tax

Tax Rate

24%

32%

34%

29%

28%

23%

29%

40%

33%

26%

PAT

204

141

PAT before Minority Interest

204

141

Minority Interest

-1

PAT Margin

11%

PAT Growth

130%

58%

19%

-11%

229%

-16%

68%

19%

EPS

87.73

60.69

38.52

35.33

35.11

29.49

33.15

10.09

12.04

7.17

6.04

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 622 519 433 387 350 304 251 208 176 157 Share Capital 23 24 24 24 24 24 12 12 12 12 Total Reserves 598 495 410 363 326 279 239 196 164 144 Non-Current Liabilities 293 314 294 280 227 199 119 121 99 104 Secured Loans 168 187 174 173 161 141 77 68 67 74 Unsecured Loans 9 9 12 14 15 11 0 13 0 0 Long Term Provisions 24 20 17 9 1 0 0 3 0 0 Current Liabilities 556 547 589 449 477 464 480 391 337 255 Trade Payables 316 228 240 170 164 150 150 132 94 77 Other Current Liabilities 81 71 52 48 42 41 44 30 29 24 Short Term Borrowings 155 246 296 230 257 251 266 215 206 147 Short Term Provisions 4 1 1 2 13 22 20 14 9 6 Total Liabilities 1,471 1,380 1,316 1,116 1,055 967 850 720 613 516 Net Block 612 586 564 542 463 431 373 291 274 224 Gross Block 991 922 862 804 691 665 581 479 439 346 Accumulated Depreciation 380 337 299 261 228 234 209 188 166 122 Non Current Assets 645 645 620 587 513 460 392 312 286 268 Capital Work in Progress 11 32 28 14 34 13 8 13 3 10 Non Current Investment 20 19 17 18 11 11 5 5 7 25 Long Term Loans & Adv. 2 8 11 12 5 4 7 3 2 9 Other Non Current Assets 0 0 0 0 0 0 0 0 0 0 Current Assets 825 735 697 529 542 507 457 408 327 248 Current Investments 0 0 0 0 0 0 0 0 0 0 Inventories 307 228 254 189 167 153 127 141 98 83 Sundry Debtors 464 437 365 278 321 308 277 216 181 126 Cash & Bank 4 5 4 4 4 3 4 3 5 4 Other Current Assets 50 7 10 0 49 42 50 49 43 35 Short Term Loans & Adv. 48 59 63 58 49 42 41 32 30 25 Net Current Assets 269 188 108 80 65 42 -22 17 -10 -7 Total Assets 1,471 1,380 1,316 1,116 1,055 967 850 720 613 516

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

622

519

433

387

350

304

251

208

176

157

Share Capital

Total Reserves

598

495

410

363

326

279

239

196

164

144

Non-Current Liabilities

293

314

294

280

227

199

119

121

104

Secured Loans

168

187

174

173

161

141

Unsecured Loans

Long Term Provisions

Current Liabilities

556

547

589

449

477

464

480

391

337

255

Trade Payables

316

228

240

170

164

150

132

Other Current Liabilities

Short Term Borrowings

155

246

296

230

257

251

266

215

206

147

Short Term Provisions

Total Liabilities

1,471

1,380

1,316

1,116

1,055

967

850

720

613

516

Net Block

612

586

564

542

463

431

373

291

274

224

Gross Block

991

922

862

804

691

665

581

479

439

346

Accumulated Depreciation

380

337

299

261

228

234

209

188

166

122

Non Current Assets

645

620

587

513

460

392

312

286

268

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

825

735

697

529

542

507

457

408

327

248

Current Investments

Inventories

307

228

254

189

167

153

127

141

Sundry Debtors

464

437

365

278

321

308

277

216

181

126

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

269

188

108

-22

-10

-7

Total Assets

1,471

1,380

1,316

1,116

1,055

967

850

720

613

516

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 11 Mar 10 Mar 09 Mar 08
Shareholder's Funds 652 543 455 400 357 308 163 146 123 112 Share Capital 23 24 24 24 24 24 12 12 12 12 Total Reserves 629 520 432 376 333 284 151 134 112 100 Non-Current Liabilities 299 328 312 297 244 211 290 210 211 233 Secured Loans 172 200 191 187 177 153 205 139 161 128 Unsecured Loans 9 9 12 14 15 11 63 50 31 90 Long Term Provisions 24 20 17 8 1 0 0 0 0 0 Current Liabilities 625 591 622 494 501 483 70 58 60 57 Trade Payables 330 243 259 197 185 167 65 50 55 54 Other Current Liabilities 133 83 56 51 44 42 2 2 1 1 Short Term Borrowings 158 263 306 245 258 252 0 0 0 0 Short Term Provisions 5 2 1 2 14 22 3 6 4 2 Total Liabilities 1,576 1,463 1,389 1,191 1,102 1,002 523 419 403 417 Net Block 644 625 602 581 493 448 248 208 205 190 Gross Block 1,031 972 909 848 725 685 393 332 310 278 Accumulated Depreciation 387 347 307 267 232 237 145 124 105 88 Non Current Assets 672 679 653 620 537 476 264 213 207 218 Capital Work in Progress 12 33 28 14 34 16 10 3 1 15 Non Current Investment 13 12 11 12 5 5 5 2 2 13 Long Term Loans & Adv. 3 9 11 12 5 7 0 0 0 0 Other Non Current Assets 0 0 0 0 0 0 0 0 0 0 Current Assets 904 784 737 571 565 526 260 206 196 199 Current Investments 0 0 0 0 0 0 0 0 0 0 Inventories 325 247 278 210 178 164 92 64 61 66 Sundry Debtors 489 459 375 297 332 314 121 116 113 103 Cash & Bank 8 6 4 4 5 4 5 9 3 4 Other Current Assets 82 7 10 0 50 43 42 17 18 25 Short Term Loans & Adv. 76 67 69 61 50 43 41 16 18 24 Net Current Assets 279 193 115 77 64 43 190 148 136 141 Total Assets 1,576 1,463 1,389 1,191 1,102 1,002 523 419 403 417

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 11

Mar 10

Mar 09

Mar 08

Shareholder's Funds

652

543

455

400

357

308

163

146

123

112

Share Capital

Total Reserves

629

520

432

376

333

284

151

134

112

100

Non-Current Liabilities

299

328

312

297

244

211

290

210

211

233

Secured Loans

172

200

191

187

177

153

205

139

161

128

Unsecured Loans

Long Term Provisions

Current Liabilities

625

591

622

494

501

483

Trade Payables

330

243

259

197

185

167

Other Current Liabilities

133

Short Term Borrowings

158

263

306

245

258

252

Short Term Provisions

Total Liabilities

1,576

1,463

1,389

1,191

1,102

1,002

523

419

403

417

Net Block

644

625

602

581

493

448

248

208

205

190

Gross Block

1,031

972

909

848

725

685

393

332

310

278

Accumulated Depreciation

387

347

307

267

232

237

145

124

105

Non Current Assets

672

679

653

620

537

476

264

213

207

218

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

904

784

737

571

565

526

260

206

196

199

Current Investments

Inventories

325

247

278

210

178

164

Sundry Debtors

489

459

375

297

332

314

121

116

113

103

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

279

193

115

190

148

136

141

Total Assets

1,576

1,463

1,389

1,191

1,102

1,002

523

419

403

417

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 196 147 62 174 125 107 95 72 44 28 PBT 175 128 112 108 93 100 85 66 32 31 Adjustment 80 70 71 68 78 69 61 53 50 33 Changes in Working Capital -21 -22 -99 18 -26 -47 -24 -34 -31 -28 Cash after chg. in Working capital 233 176 84 194 145 122 122 86 51 37 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -37 -29 -22 -20 -20 -15 -27 -14 -7 -9 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -29 -59 -71 -96 -87 -102 -105 -58 -48 -74 Net Fixed Assets -47 -64 -73 -93 -46 -89 -98 -49 -86 -65 Net Investments -1 -2 1 -7 0 -6 1 2 18 -3 Others 20 7 0 4 -41 -7 -7 -11 21 -5 Cash from Financing Activity -168 -87 9 -78 -37 -5 11 -16 3 45 Net Cash Inflow / Outflow -1 1 0 0 1 -1 2 -2 0 0 Opening Cash & Equivalents 4 3 3 3 3 4 3 5 5 4 Closing Cash & Equivalent 3 4 3 3 4 3 4 3 5 4

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

196

147

174

125

107

PBT

175

128

112

108

100

Adjustment

Changes in Working Capital

-21

-22

-99

-26

-47

-24

-34

-31

-28

Cash after chg. in Working capital

233

176

194

145

122

Interest Paid

Tax Paid

-37

-29

-22

-20

-15

-27

-14

-7

-9

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-29

-59

-71

-96

-87

-102

-105

-58

-48

-74

Net Fixed Assets

-47

-64

-73

-93

-46

-89

-98

-49

-86

-65

Net Investments

-1

-2

-7

-6

-3

Others

-41

-7

-11

-5

Cash from Financing Activity

-168

-87

-78

-37

-5

-16

Net Cash Inflow / Outflow

-1

-2

Opening Cash & Equivalents

Closing Cash & Equivalent

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 11 Mar 10 Mar 09 Mar 08
Cash From Operating Activity 251 143 70 175 133 105 21 59 65 28 PBT 185 131 124 116 95 100 33 47 26 20 Adjustment 87 75 75 72 79 69 39 39 42 28 Changes in Working Capital 19 -33 -105 8 -21 -50 -40 -13 2 -15 Cash after chg. in Working capital 292 173 94 196 153 120 32 73 70 32 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -41 -30 -25 -21 -20 -15 -11 -14 -5 -4 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -33 -62 -74 -107 -99 -107 -76 -30 -12 -33 Net Fixed Assets -47 -64 -73 -93 -46 -322 -65 -23 -20 -22 Net Investments -1 -2 1 -7 0 14 -3 0 12 -12 Others 16 4 -2 -7 -52 202 -8 -7 -4 1 Cash from Financing Activity -215 -80 4 -68 -33 1 53 -24 -54 4 Net Cash Inflow / Outflow 2 1 0 0 1 -1 -3 5 -1 -1 Opening Cash & Equivalents 5 3 3 4 4 5 9 3 4 5 Closing Cash & Equivalent 7 5 3 3 5 4 5 9 3 4

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 11

Mar 10

Mar 09

Mar 08

Cash From Operating Activity

251

143

175

133

105

PBT

185

131

124

116

100

Adjustment

Changes in Working Capital

-33

-105

-21

-50

-40

-13

-15

Cash after chg. in Working capital

292

173

196

153

120

Interest Paid

Tax Paid

-41

-30

-25

-21

-20

-15

-11

-14

-5

-4

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-33

-62

-74

-107

-99

-107

-76

-30

-12

-33

Net Fixed Assets

-47

-64

-73

-93

-46

-322

-65

-23

-20

-22

Net Investments

-1

-2

-7

-3

-12

Others

-2

-7

-52

202

-8

-7

-4

Cash from Financing Activity

-215

-80

-68

-33

-24

-54

Net Cash Inflow / Outflow

-1

-3

-1

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 67 220 184 162 145 125 104 86 73 65 ROA 10% 6% 6% 7% 7% 9% 8% 7% 4% 5% ROE 24% 18% 18% 20% 20% 28% 27% 24% 13% 15% ROCE 21% 17% 17% 18% 18% 21% 21% 19% 14% 14% Fixed Asset Turnover 1.71 1.63 1.39 1.59 1.73 1.88 1.97 1.93 1.79 1.65 Receivable days 101 101 101 92 98 91 86 82 80 85 Inventory Days 60 60 70 55 50 44 47 49 47 49 Payable days 68 69 72 65 62 57 61 56 52 55 Cash Conversion Cycle 92 92 99 82 85 77 71 75 74 80 Total Debt/Equity 0.59 0.91 1.19 1.16 1.23 1.43 1.51 1.54 1.69 1.42 Interest Cover 6 4 4 4 3 3 3 3 2 3

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

220

184

162

145

125

104

ROA

10%

ROE

24%

18%

20%

28%

27%

24%

13%

15%

ROCE

21%

17%

18%

21%

19%

14%

Fixed Asset Turnover

1.71

1.63

1.39

1.59

1.73

1.88

1.97

1.93

1.79

1.65

Receivable days

101

Inventory Days

Payable days

Cash Conversion Cycle

Total Debt/Equity

0.59

0.91

1.19

1.16

1.23

1.43

1.51

1.54

1.69

1.42

Interest Cover

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 11 Mar 10 Mar 09 Mar 08
Book Value (Rs.) 70 230 193 168 148 127 67 60 53 48 ROA 9% 6% 6% 7% 7% 10% 5% 7% 4% 4% ROE 24% 18% 19% 22% 21% 33% 15% 21% 15% 14% ROCE 21% 17% 17% 18% 18% 24% 13% 20% 16% 11% Fixed Asset Turnover 1.81 1.66 1.44 1.64 1.75 2.19 1.45 1.57 1.42 1.26 Receivable days 96 97 97 89 96 67 82 83 95 99 Inventory Days 58 61 71 55 51 40 54 45 56 70 Payable days 65 68 74 68 66 46 46 47 63 60 Cash Conversion Cycle 89 91 94 76 81 61 90 81 88 109 Total Debt/Equity 0.58 0.93 1.20 1.20 1.26 1.45 1.64 1.29 1.56 1.95 Interest Cover 6 4 4 4 3 3 3 4 2 2

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 11

Mar 10

Mar 09

Mar 08

Book Value (Rs.)

230

193

168

148

127

ROA

10%

ROE

24%

18%

19%

22%

21%

33%

15%

21%

15%

14%

ROCE

21%

17%

18%

24%

13%

20%

16%

11%

Fixed Asset Turnover

1.81

1.66

1.44

1.64

1.75

2.19

1.45

1.57

1.42

1.26

Receivable days

Inventory Days

Payable days

Cash Conversion Cycle

109

Total Debt/Equity

0.58

0.93

1.20

1.26

1.45

1.64

1.29

1.56

1.95

Interest Cover

Aarti Drugs Ltd.

Pharmaceuticals & Drugs - API

BSE: 524348 | NSE: AARTIDRUGS

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update

Aarti Drugs Ltd.

Pharmaceuticals & Drugs - API

BSE: 524348 | NSE: AARTIDRUGS

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update